REMSleep Holdings, Inc.

Equities

RMSL

US75990A2006

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 03:58:50 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0105 ^USD	+5.00%		+9.38%	-32.26%

Apr. 16	REMSleep Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	REMSleep Holdings, Inc. cancelled the transaction announced on September 18, 2023	CI

REMSleep Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023

August 18, 2023 at 06:11 am EDT

REMSleep Holdings, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.05866 million compared to USD 0.11967 million a year ago. Net loss was USD 0.223198 million compared to USD 0.440292 million a year ago.
For the six months, sales was USD 0.144315 million compared to USD 0.11967 million a year ago. Net loss was USD 0.449457 million compared to USD 0.756591 million a year ago.

Latest news about REMSleep Holdings, Inc.

REMSleep Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
REMSleep Holdings, Inc. cancelled the transaction announced on September 18, 2023	Dec. 14	CI
REMSleep Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
Remsleep Holdings Inc.'s Deltawave Mask Moves to Substantive Review of FDA 510K Process	Nov. 02	CI
Gold takes a breather as investors await US economic data	23-10-23	RE
RemSleep Holdings Inc. Announces Submission of DeltaWave Mask for FDA 510K Review	23-10-06	CI
REMSleep Holdings, Inc. announced that it expects to receive funding from JanBella Group, LLC	23-09-17	CI
Remsleep Holdings Inc. Announces Completion of Deltawave Cpap Mask	23-09-01	CI
REMSleep Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
Remsleep Holdings, Inc. Announces Resignation of Russell Bird as Officer and Chairman of the Board	23-07-12	CI
Bank of Korea: less desirable to increase gold holdings at this point	23-06-05	RE
REMSleep Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
REMSleep Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
REMSleep Holdings, Inc. Auditor Raises 'Going Concern' Doubt	23-04-16	CI
REMSleep Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
REMSleep Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
REMSleep Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
REMSleep Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
REMSleep Holdings, Inc. Auditor Raises 'Going Concern' Doubt	22-03-28	CI
REMSleep Holdings, Inc. Announces Significant Distribution Agreement for Nasal CPAP Machines to Address USA CPAP Shortage	22-03-22	CI
REMSleep Holdings, Inc. Announces Completion of Testing for ISO 18562-4:2017	22-01-05	CI
REMSleep Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
REMSleep Holdings, Inc. Announces Condensation Testing Per ISO 18562-4 :2017	21-11-10	CI
Remsleep Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
REMSleep Holdings, Inc. Files 510K Submission for Deltawave CPAP Pillows Interface Mask	21-07-06	CI

Chart REMSleep Holdings, Inc.

Duration

Period

More charts

Company Profile

REMSleep Holdings, Inc. is a medical technology company. The Company is focused on the development and commercialization of solutions for patients with obstructive sleep apnea. Its DeltaWave CPAP interface (the DeltaWave), which is a device to treat patients with sleep apnea. The patent-pending DeltaWave product is a nasal-pillow type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. The Companyâs product is manufactured by mold makers. It has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
REMSLEEP HOLDINGS, INC.	-32.26%	15.35M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution